Is NXGL or ICCM more profitable?

NexGel has a net margin of -28.54% compared to IceCure Medical's net margin of -441.60%. NexGel's return on equity of -64.29% beat IceCure Medical's return on equity. Company Net Margins Return on Equity Return on Assets NexGel -28.54% -64.29% -29.64% IceCure Medical -441.60% -211.73% -119.13%

Does the media refer more to NXGL or ICCM?

In the previous week, NexGel and NexGel both had 3 articles in the media. NexGel's average media sentiment score of -0.33 beat IceCure Medical's score of -0.67 indicating that NexGel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NexGel 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IceCure Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Which has higher earnings & valuation, IRIX or NXGL?

NexGel has lower revenue, but higher earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A NexGel $11.42M 0.44 -$3M -$0.40 N/A

Is IRIX or NXGL more profitable?

IRIDEX has a net margin of -6.23% compared to NexGel's net margin of -28.54%. NexGel's return on equity of -64.29% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% -1,204.74% -11.16% NexGel -28.54% -64.29% -29.64%

Does the media favor IRIX or NXGL?

In the previous week, NexGel had 2 more articles in the media than IRIDEX. MarketBeat recorded 3 mentions for NexGel and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.00 beat NexGel's score of -0.33 indicating that IRIDEX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NexGel 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ZJYL or NXGL?

NexGel has a consensus price target of $2.00, suggesting a potential upside of 262.98%. Given NexGel's stronger consensus rating and higher probable upside, analysts clearly believe NexGel is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NexGel 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation and earnings, ZJYL or NXGL?

Jin Medical International has higher revenue and earnings than NexGel. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 0.85 $1.19M N/A N/A NexGel $11.42M 0.44 -$3M -$0.40 N/A

Does the media favor ZJYL or NXGL?

In the previous week, NexGel had 2 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for NexGel and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.00 beat NexGel's score of -0.33 indicating that Jin Medical International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jin Medical International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NexGel 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend NXGL or OSRH?

NexGel currently has a consensus target price of $2.00, indicating a potential upside of 262.98%. Given NexGel's stronger consensus rating and higher possible upside, equities research analysts plainly believe NexGel is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, NXGL or OSRH?

NexGel has higher revenue and earnings than OSR. NexGel is trading at a lower price-to-earnings ratio than OSR, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NexGel $11.42M 0.44 -$3M -$0.40 N/A OSR $2.91M 4.86 -$27.06M -$0.33 N/A

Is NXGL or OSRH more profitable?

NexGel has a net margin of -28.54% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets NexGel -28.54% -64.29% -29.64% OSR -363.26% -7.24% -5.41%

Does the media prefer NXGL or OSRH?

In the previous week, NexGel and NexGel both had 3 articles in the media. OSR's average media sentiment score of 0.60 beat NexGel's score of -0.33 indicating that OSR is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NexGel 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OSR 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, HIND or NXGL?

NexGel has higher revenue and earnings than Vyome. NexGel is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 48.04 -$10.26M -$12.27 N/A NexGel $11.42M 0.44 -$3M -$0.40 N/A

Is HIND or NXGL more profitable?

NexGel has a net margin of -28.54% compared to Vyome's net margin of -270.58%. NexGel's return on equity of -64.29% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome -270.58% -203.92% -134.16% NexGel -28.54% -64.29% -29.64%

Does the media favor HIND or NXGL?

In the previous week, NexGel had 1 more articles in the media than Vyome. MarketBeat recorded 3 mentions for NexGel and 2 mentions for Vyome. Vyome's average media sentiment score of 0.00 beat NexGel's score of -0.33 indicating that Vyome is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vyome 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NexGel 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

NexGel (NXGL) Competitors

$0.55 -0.01 (-1.69%)

Closing price 06/8/2026 04:00 PM Eastern

Extended Trading

$0.58 +0.03 (+5.81%)

As of 06/8/2026 06:04 PM Eastern

Compare

NXGL vs. ICCM, IRIX, ZJYL, OSRH, and HIND

Should you buy NexGel stock or one of its competitors? MarketBeat compares NexGel with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NexGel include IceCure Medical (ICCM), IRIDEX (IRIX), Jin Medical International (ZJYL), OSR (OSRH), and Vyome (HIND). These companies are all part of the "medical equipment" industry.

How does NexGel compare to IceCure Medical?

NexGel (NASDAQ:NXGL) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

In the previous week, NexGel and NexGel both had 3 articles in the media. NexGel's average media sentiment score of -0.33 beat IceCure Medical's score of -0.67 indicating that NexGel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NexGel	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IceCure Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

NexGel has higher revenue and earnings than IceCure Medical. NexGel is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.44	-$3M	-$0.40	N/A
IceCure Medical	$3.38M	3.03	-$15.06M	-$7.21	N/A

2.2% of NexGel shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 20.6% of NexGel shares are held by company insiders. Comparatively, 2.4% of IceCure Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

NexGel has a net margin of -28.54% compared to IceCure Medical's net margin of -441.60%. NexGel's return on equity of -64.29% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-28.54%	-64.29%	-29.64%
IceCure Medical	-441.60%	-211.73%	-119.13%

NexGel has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market.

NexGel presently has a consensus target price of $2.00, suggesting a potential upside of 262.98%. IceCure Medical has a consensus target price of $62.70, suggesting a potential upside of 1,622.53%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts clearly believe IceCure Medical is more favorable than NexGel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

NexGel beats IceCure Medical on 10 of the 15 factors compared between the two stocks.

How does NexGel compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and NexGel (NASDAQ:NXGL) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

IRIDEX currently has a consensus target price of $3.00, suggesting a potential upside of 170.27%. NexGel has a consensus target price of $2.00, suggesting a potential upside of 262.98%. Given NexGel's higher probable upside, analysts plainly believe NexGel is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

NexGel has lower revenue, but higher earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A
NexGel	$11.42M	0.44	-$3M	-$0.40	N/A

In the previous week, NexGel had 2 more articles in the media than IRIDEX. MarketBeat recorded 3 mentions for NexGel and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.00 beat NexGel's score of -0.33 indicating that IRIDEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NexGel	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 8.6% of IRIDEX shares are held by company insiders. Comparatively, 20.6% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

IRIDEX has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, NexGel has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

IRIDEX has a net margin of -6.23% compared to NexGel's net margin of -28.54%. NexGel's return on equity of -64.29% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
NexGel	-28.54%	-64.29%	-29.64%

Summary

NexGel beats IRIDEX on 8 of the 14 factors compared between the two stocks.

How does NexGel compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Jin Medical International has a beta of 7.24, meaning that its share price is 624% more volatile than the broader market. Comparatively, NexGel has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

2.2% of NexGel shares are held by institutional investors. 20.6% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Jin Medical International has a net margin of 0.00% compared to NexGel's net margin of -28.54%. Jin Medical International's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
NexGel	-28.54%	-64.29%	-29.64%

NexGel has a consensus price target of $2.00, suggesting a potential upside of 262.98%. Given NexGel's stronger consensus rating and higher probable upside, analysts clearly believe NexGel is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Jin Medical International has higher revenue and earnings than NexGel.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	0.85	$1.19M	N/A	N/A
NexGel	$11.42M	0.44	-$3M	-$0.40	N/A

In the previous week, NexGel had 2 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for NexGel and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.00 beat NexGel's score of -0.33 indicating that Jin Medical International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jin Medical International	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NexGel	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Jin Medical International beats NexGel on 8 of the 14 factors compared between the two stocks.

How does NexGel compare to OSR?

NexGel (NASDAQ:NXGL) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.

2.2% of NexGel shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 20.6% of NexGel shares are held by insiders. Comparatively, 36.8% of OSR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

NexGel has a net margin of -28.54% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-28.54%	-64.29%	-29.64%
OSR	-363.26%	-7.24%	-5.41%

In the previous week, NexGel and NexGel both had 3 articles in the media. OSR's average media sentiment score of 0.60 beat NexGel's score of -0.33 indicating that OSR is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NexGel	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OSR	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NexGel has higher revenue and earnings than OSR. NexGel is trading at a lower price-to-earnings ratio than OSR, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.44	-$3M	-$0.40	N/A
OSR	$2.91M	4.86	-$27.06M	-$0.33	N/A

NexGel currently has a consensus target price of $2.00, indicating a potential upside of 262.98%. Given NexGel's stronger consensus rating and higher possible upside, equities research analysts plainly believe NexGel is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NexGel has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, OSR has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

Summary

OSR beats NexGel on 8 of the 15 factors compared between the two stocks.

How does NexGel compare to Vyome?

Vyome (NASDAQ:HIND) and NexGel (NASDAQ:NXGL) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

22.1% of Vyome shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 33.0% of Vyome shares are held by insiders. Comparatively, 20.6% of NexGel shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Vyome currently has a consensus target price of $15.00, suggesting a potential upside of 584.93%. NexGel has a consensus target price of $2.00, suggesting a potential upside of 262.98%. Given Vyome's stronger consensus rating and higher probable upside, equities analysts plainly believe Vyome is more favorable than NexGel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

NexGel has a net margin of -28.54% compared to Vyome's net margin of -270.58%. NexGel's return on equity of -64.29% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	-270.58%	-203.92%	-134.16%
NexGel	-28.54%	-64.29%	-29.64%

Vyome has a beta of 1.48, suggesting that its share price is 48% more volatile than the broader market. Comparatively, NexGel has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

In the previous week, NexGel had 1 more articles in the media than Vyome. MarketBeat recorded 3 mentions for NexGel and 2 mentions for Vyome. Vyome's average media sentiment score of 0.00 beat NexGel's score of -0.33 indicating that Vyome is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vyome	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NexGel	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NexGel has higher revenue and earnings than Vyome. NexGel is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	48.04	-$10.26M	-$12.27	N/A
NexGel	$11.42M	0.44	-$3M	-$0.40	N/A

Summary

Vyome beats NexGel on 9 of the 16 factors compared between the two stocks.

Get NexGel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NXGL vs. The Competition

Export

Metric	NexGel	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.12M	$7.25B	$6.48B	$11.99B
Dividend Yield	N/A	1.19%	2.67%	5.58%
P/E Ratio	-1.38	46.41	23.69	23.74
Price / Sales	0.44	72.50	513.81	108.85
Price / Cash	N/A	25.19	26.99	37.25
Price / Book	0.92	6.89	10.41	6.78
Net Income	-$3M	$159.22M	$3.57B	$337.51M
7 Day Performance	-5.16%	-2.53%	0.28%	-2.34%
1 Month Performance	-7.11%	2.25%	3.27%	1.88%
1 Year Performance	-76.85%	-3.61%	22.25%	25.55%

NexGel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NXGL NexGel	2.7709 of 5 stars	$0.55 -1.7%	$2.00 +263.0%	-76.1%	$5.12M	$11.42M	N/A	10	Gap Up
ICCM IceCure Medical	2.8053 of 5 stars	$0.23 -0.5%	$2.09 +827.7%	-88.0%	$18.40M	$3.38M	N/A	60
IRIX IRIDEX	1.8737 of 5 stars	$1.03 -1.0%	$3.00 +191.3%	+14.1%	$18.10M	$52.67M	N/A	120
ZJYL Jin Medical International	0.284 of 5 stars	$2.18 -4.4%	N/A	-85.4%	$17.85M	$20.69M	N/A	245	Gap Down
OSRH OSR	0.931 of 5 stars	$0.48 -2.2%	N/A	-70.4%	$17.38M	$2.91M	N/A	N/A	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NXGL) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NexGel (NXGL) Competitors

NXGL vs. ICCM, IRIX, ZJYL, OSRH, and HIND

How does NexGel compare to IceCure Medical?

Summary

How does NexGel compare to IRIDEX?

Summary

How does NexGel compare to Jin Medical International?

Summary

How does NexGel compare to OSR?

Summary

How does NexGel compare to Vyome?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NexGel (NXGL) Competitors

NXGL vs. ICCM, IRIX, ZJYL, OSRH, and HIND

How does NexGel compare to IceCure Medical?

Does the media refer more to NXGL or ICCM?

Which has preferable earnings and valuation, NXGL or ICCM?

Do institutionals and insiders believe in NXGL or ICCM?

Is NXGL or ICCM more profitable?

Which has more volatility and risk, NXGL or ICCM?

Do analysts rate NXGL or ICCM?

Summary

How does NexGel compare to IRIDEX?

Do analysts prefer IRIX or NXGL?

Which has higher earnings & valuation, IRIX or NXGL?

Does the media favor IRIX or NXGL?

Do institutionals & insiders hold more shares of IRIX or NXGL?

Which has more volatility and risk, IRIX or NXGL?

Is IRIX or NXGL more profitable?

Summary

How does NexGel compare to Jin Medical International?

Which has more volatility and risk, ZJYL or NXGL?

Do insiders & institutionals hold more shares of ZJYL or NXGL?

Is ZJYL or NXGL more profitable?

Do analysts rate ZJYL or NXGL?

Which has better valuation and earnings, ZJYL or NXGL?

Does the media favor ZJYL or NXGL?

Summary

How does NexGel compare to OSR?

Do insiders & institutionals have more ownership in NXGL or OSRH?

Is NXGL or OSRH more profitable?

Does the media prefer NXGL or OSRH?

Which has better earnings and valuation, NXGL or OSRH?

Do analysts recommend NXGL or OSRH?

Which has more volatility & risk, NXGL or OSRH?

Summary

How does NexGel compare to Vyome?

Do institutionals & insiders believe in HIND or NXGL?

Do analysts rate HIND or NXGL?

Is HIND or NXGL more profitable?

Which has more risk and volatility, HIND or NXGL?

Does the media favor HIND or NXGL?

Which has better earnings and valuation, HIND or NXGL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools